The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces actin filament polymerization in HL-60 cells undergoing differentiation.

被引：0
|
作者：
Yao, Y [1 ]
Zhou, Q [1 ]
Ericson, SG [1 ]
机构：
[1] W Virginia Univ, Mary Babb Randolph Canc Ctr, Hematol Malignancy Program, Morgantown, WV 26506 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4543
引用
收藏
页码：206B / 206B
页数：1
相关论文
共 50 条
  • [1] The Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid (SAHA) Induces Differentiation of Intestinal Cells
    Roostaee, Alireza
    Benoit, Yannick D.
    Guezguez, Amel
    Simoneau, Aline
    Beaulieu, Jean-Francois
    GASTROENTEROLOGY, 2014, 146 (05) : S785 - S785
  • [2] The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces differentiation of human breast cancer cells.
    Munster, PN
    Rosen, N
    Rifkind, R
    Marks, P
    Richon, V
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3725S - 3725S
  • [3] Apicidin, a histone deacetylase inhibitor, induces differentiation of HL-60 cells
    Hong, JJ
    Ishihara, K
    Yamaki, K
    Hiraizumi, K
    Ohno, T
    Ahn, JW
    Zee, O
    Ohuchi, K
    CANCER LETTERS, 2003, 189 (02) : 197 - 206
  • [4] The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells
    Munster, PN
    Troso-Sandoval, T
    Rosen, N
    Rifkind, R
    Marks, PA
    Richon, VM
    CANCER RESEARCH, 2001, 61 (23) : 8492 - 8497
  • [5] The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcoma
    Ghayad, Sandra E.
    Rammal, Ghina
    Sarkis, Omar
    Basma, Hussein
    Ghamloush, Farah
    Fahs, Assil
    Karam, Mia
    Harajli, Mohamad
    Rabeh, Wissam
    Mouawad, Joe E.
    Zalzali, Hassan
    Saab, Raya
    CANCER BIOLOGY & THERAPY, 2019, 20 (03) : 272 - 283
  • [6] The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) radiosensitizes osteosarcoma cells in vitro and in vivo
    Schlaich, F.
    Blattmann, C.
    Thiemann, M.
    Kulozik, A. E.
    Debus, J.
    Oertel, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 : 119 - 120
  • [7] Inhibition of oral carcinogenesis in rats by the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA)
    McCormick, David L.
    Horn, Thomas L.
    Johnson, William D.
    Lubet, Ronald A.
    Steele, Vernon E.
    CANCER RESEARCH, 2011, 71
  • [8] The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces growth arrest and apoptosis in human retinoblastoma cell lines
    Poulaki, V
    Joussen, A
    Iliaki, E
    Mitsiades, CS
    Fanourakis, G
    Mitsiades, N
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U255 - U255
  • [9] The mechanism of the anti-tumor activity of the histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA)
    Marks, PA
    CELL CYCLE, 2004, 3 (05) : 534 - 535
  • [10] Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells
    Kumagai, Takashi
    Wakimoto, Naoki
    Yin, Dong
    Gery, Sigal
    Kawamata, Norihiko
    Takai, Noriyuki
    Komatsu, Naoki
    Chumakov, Alexy
    Imai, Yasufumi
    Koeffler, H. Phillip
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (03) : 656 - 665
12345